The plan is that Ankur’s facility in Nalagarh in Solan, Himachal Pradesh, will boost Akums’ production capacities for general oral tablets and oral liquids by 6 billion units of tablets and 90 million units of oral liquids per annum
Akums Drugs & Pharmaceuticals has recently acquired a facility from Ankur Drugs and Pharmaceuticals. With this acquisition Akums’ will boost its production capacities for general oral tablets and oral liquids. The planned capacities of the new facility are six billion units of tablets and 90 million units of oral liquids per annum. This facility is most likely to be fully operational by the end of 2022.
Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Sandeep Jain says, “What the addition of this new facility means to our existing network is to step up our continuous efforts to serve our customers efficiently and the nation better. We, at Akums, are already leading the market in many areas and, hence, we also know there is so much yet to be done. With this new facility in Nalagarh in Solan, Himachal Pradesh, we are trying to bridge some more capacity gaps in the pharma industry.”
Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain says, “In 2021, our supplies made up approximately 12 per cent of the total market. With this new facility acquisition in the state of Himachal Pradesh and our previous acquisition in Kotdwar, Uttarakhand, in August 2021, we have bolstered our total capacity further. This expansion is a step towards achieving our goal of 20 per cent market share. The operations at our Kotdwar plant have begun recently, while our new plant in Himachal Pradesh is likely to start its operations by December 2022.”